Behavioral chronic migraine treatment such as relaxation training, hypnosis and biofeedback makes financial sense in comparison to prescription medication, particularly after a year or longer. The costs of prescription medications, the type chronic migraine sufferers use on a daily basis in order to prevent onset, might not appear to be much even at a few… Read More »
New research appearing in the BMJ journal Evidence-Based Mental Health suggests that mindfulness could be a promising alternative to cognitive behavioral therapy for relieving some of the psychological and physical symptoms of chronic pain. Mindfulness may be a useful alternative to CBT for easing chronic pain, new research shows. According to the most recent survey… Read More »
A new study has shown that drinking too much tea or beer can lead to chronic kidney disease. This is the perfect excuse to start your 2019 resolutions of right! Researchers from Johns Hopkins Bloomberg School of Public Health, in Baltimore, examined survey data on drink consumption among 3,003 African-American men and women who all had kidney… Read More »
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More »